Skip to content
Disclosery

FCPM III SERVICES B.V.

Follow

13F filer, CIK 2013410, NAARDEN, Netherlands

FCPM III SERVICES B.V. reported $413,711,245 across 7 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-005517

Period
2025-03-31
Reported value
$414M
Holdings
7
Top 10 weight
100%
New
0
Sold out
1

Part of the filer group FCPM III SERVICES B.V.

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NAMSadded+338,129$6.92M
ASTRIA THERAPEUTICS INCadded+950,000$5.07M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ACHILLES THERAPEUTICS PL-ADRexited-2,390,050-$2.75M
REPLreduced-60,972-$594K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0000950123-25-005517, largest first. % of portfolio is the value over $413,711,245, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,831,461 shares; 2024Q4: 10,597,181 shares; 2025Q1: 10,935,310 shares 10,935,310$224M54.11%+338,129Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,954,069 shares; 2024Q4: 5,462,846 shares; 2025Q1: 5,462,846 shares 5,462,846$57.1M13.81%0Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,677,951 shares; 2024Q4: 9,632,561 shares; 2025Q1: 9,632,561 shares 9,632,561$43.2M10.43%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,866,449 shares; 2024Q4: 3,970,668 shares; 2025Q1: 3,909,696 shares 3,909,696$38.1M9.21%-60,972Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,339,961 shares; 2024Q4: 3,452,330 shares; 2025Q1: 3,452,330 shares 3,452,330$29.3M7.08%0Timeline
ASTRIA THERAPEUTICS INCASTRIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,872,537 shares; 2025Q1: 3,822,537 shares 3,822,537$20.4M4.93%+950,000
ENGNWENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,878,148 shares; 2024Q4: 2,878,148 shares; 2025Q1: 2,878,148 shares 2,878,148$1.73M0.42%0Timeline

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ACHILLES THERAPEUTICS PL-ADRACHILLES THERAPEUTICS PL-ADR2,390,050$2.75Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-005517 base2025-05-15acceptance time not in the bulk data set